logo

For the Inventor, By the Inventor

Madison, WI, United States of America

Henry A Lardy

This inventor holds 24 USPTO granted patents and 1 published patent application, primarily in Androstene Compounds. Top assignees: - Humanetics Corporation, Hollis-Eden Pharmaceuticals, Inc., Harbor Biosciences, Inc.. Active years: 1994-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henry A Lardy. Retrieved from https://idiyas.com/inventor/henry-a-lardy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 70.8

Average Co-Inventor Count = 1.8

ph-index = 10

Forward Citations = 280(Granted Patents)


Company Filing History:

goldMedal15 out of 47 
 
- Humanetics Corporation
 patents
silverMedal4 out of 11 
 
Hollis-Eden Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 12 
 
Harbor Biosciences, Inc.
 patents
4. 1 out of 1 
 
Humanetic Corp.
 patent
5. 3 out of 834,570 
Other
 patents

Years Active: 1994-2010

Loading Chart...
Areas of Expertise:
Diene Compounds
Triene Compounds
Prostate Cancer Treatment
Steroids
Allylic Oxidation
Lupus Erythematosus
Memory Enhancement
Weight Control
HIV Wasting Syndrome
Immune System Modulation
Weight Maintenance
24 patents (USPTO):Explore Patents
1. 7842680 - Diene and triene compounds and formulations (2010-11-30),
2. 7638509 - Diene compounds and formulations (2009-12-29),
3. 7550450 - Prostate cancer treatment (2009-06-23),
4. 7514420 - Steroids having 1,8-unsaturation and formulations comprising same (2009-04-07),
5. 7462610 - Prostate cancer treatment (2008-12-09),
6. 6924274 - Use of Δ5-androstene-3β-ol-7,17-dione in the treatment of lupus erythematosus (2005-08-02),
7. 6686486 - Process for effecting allylic oxidation (2004-02-03),
8. 6593316 - Use of &Dgr;5-androstene-3&bgr;ol-7,17-dione in the treatment of lupus erythematosus (2003-07-15),
9. 6489313 - Memory by the administration of &Dgr;5-androstene-3&bgr;-ol-7,17-dione and 3&bgr; esters (2002-12-03),
10. 6384251 - Process for effecting allylic oxidation using dicarboxylic acid imides and chromium reagents (2002-05-07),
11. 6372732 - Use of delta5-androstene-3beta-ol-7, 17-dione in the treatment of lupus erythematosus (2002-04-16),
12. 6274746 - Process for allylic oxidation using metal hypochlorite and alkyl hydroperoxide (2001-08-14),
13. 6153606 - Memory enhancement by the administration of (2000-11-28),
14. 6111118 - Process for effecting allylic oxidation (2000-08-29),
15. 5885977 - Use of .DELTA.5 androstenes in the treatment of HIV wasting syndrome (1999-03-23),

Title: The Legacy of Henry A Lardy: Pioneering Inventor from Madison, WI

Introduction: Henry A Lardy, a distinguished inventor hailing from Madison, WI, is renowned for his groundbreaking contributions to the field of innovation and patents.

Latest Patents: Henry A Lardy's recent patents showcase his continued dedication to pushing the boundaries of technological advancement and creativity in various industries.

Career Highlights: Throughout his illustrious career, Henry A Lardy has demonstrated a remarkable ability to transform innovative ideas into tangible inventions that have significantly impacted the world of patents and intellectual property.

Collaborations: Henry A Lardy has collaborated with leading experts, companies, and research institutions to further enhance his inventions and bring them to fruition, solidifying his reputation as a visionary inventor.

Conclusion: Henry A Lardy's remarkable journey as an inventor exemplifies his unwavering passion for innovation and his relentless pursuit of excellence in the realm of patents and inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…